An acute respiratory distress syndrome drug development collaboration stimulated by the Virginia Drug Discovery Consortium is a research paper published in SLAS DISCOVERY (2023). On theSindex it has a DataRank of 0.269. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Virginia Innovation Partnership Corporation
Grant: CCF22-0064-PS
National Institutes of Health
Grant: HL158409
National Institutes of Health
Grant: CA228774
National Institutes of Health
Grant: 1R43CA228774-01A1
Developing small molecule PTP4A3 inhibitors for ovarian cancer
National Institutes of Health
Grant: 3R43HL158409-01A1S2
A PTP4A3 inhibitor for SARS-CoV-2-mediated acute lung injury
NCI NIH HHS
Grant: P30 CA044579
NHLBI NIH HHS
Grant: R43 HL158409
FWCI
0.81
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals